×

About Us
Technologies
Programs
- Oncology
- Diabetes
Clinical Trials
Investors
News
Contact

MENU

Events

Stay tuned for replay links from recent industry and investor presentations.

Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes.

(877) 774-GNPX (4679)

3300 Bee Cave Road, Suite 650-227 Austin, TX 78746

Quick Links

About Us
Clinical Trials
Investors
Downloads
Press Releases

X
Facebook
LinkedIn

Latest News

Genprex Signs Exclusive License to Additional Gene Therapy Technologies with the University of Michigan for the Treatment of Lung Cancer Nov 20
Genprex Collaborators Present Positive Preclinical Data on Reqorsa® Gene Therapy at the Society for Immunotherapy of Cancer 2024 Annual Meeting Nov 5
Genprex to Participate in 2024 BIO Europe Conference Oct 31
Genprex Collaborators Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer, Mesothelioma and Glioblastoma Oct 28

Designed and Secured by Barsec

Copyright ©2024 all rights reserved.
Home - Privacy Policy - Terms of Use